• Regulatory NewsRegulatory News

    FDA Cracks Down on Facebook Marketing With Four New Letters to Companies

    The US Food and Drug Administration (FDA) is increasingly paying attention to social media, and in particular Facebook, as companies use the social networking platform to market their products. Six Warning Letters in Six Months In at least six Warning Letters issued since October 2014, FDA has referenced promotional claims used to market products on Facebook. Warning Letter Issued to: Reason for Letter Date Issued Vitalab Co., Inc. Unapproved Claims 16 Octo...
  • Regulatory NewsRegulatory News

    FDA Calls for Changes to Drug Advertising in Hopes of Increasing Patient Understanding

    The pharmaceutical advertising you see in magazines and newspapers will soon include less information in the hopes of better conveying what the actual risk of the drug is, the US Food and Drug Administration (FDA) announced today. Background The change represents a substantial shift in policy for the agency, which has traditionally favored the inclusion of as much risk information as possible in its advertising. For example, FDA's Office of Prescription Drug Promotion (...
  • Regulatory NewsRegulatory News

    High Failure Rate for AEDs Prompts FDA Change in Regulatory Policy

    • 02 February 2015
    The US Food and Drug Administration's (FDA) has finalized a change in policy that will soon require all Automated External Defibrillators (AEDs) to undergo a more rigorous regulatory review process meant to ensure the devices—which have failed in tens of thousands of reported cases since 2005—function reliably when they are needed most. Background The move, which was first announced in 2013 , relates to the way in which FDA approves medical devices. Currently, most hig...
  • Regulatory NewsRegulatory NewsTrackersTrackers

    FDA Drug Advertising Study Tracker

    The US Food and Drug Administration (FDA) frequently studies consumer behavior, particularly as it relates to how members of the public (and medical professionals) understand pharmaceutical advertising. Our FDA Drug Advertising Study Tracker keeps tabs on these studies and explains what they're trying to accomplish in plain terms.   Date Topic Study Summary January 2012 Corrective Advertising Study to assess whether and how corrective advertising—used to cor...
  • Regulatory NewsRegulatory News

    FDA Proposal Calls for Drug Labeling to be Distributed to Doctors Electronically

    In a long-anticipated and major move, the US Food and Drug Administration (FDA) has proposed a new rule requiring biopharmaceutical companies to distribute product labeling information to healthcare providers electronically. Background The proposed rule , Electronic Distribution of Prescribing Information for Human Prescription Drugs, Including Biological Products , comes after years of development at FDA. Under Section 1140 of the 2012 Food and Drug Administratio...
  • Regulatory NewsRegulatory News

    Cosmetic Companies, Watch Out: FDA Cracking Down on Improper Claims

    In recent years, a handful of cosmetic manufacturers have come under the harsh scrutiny of the US Food and Drug Administration (FDA) over claims their products could do far more than just change the skin’s aesthetics. Now the agency is again going after a marketer of cosmetic products, saying the company’s creams and moisturizers are more like drugs than beauty products. Background Cosmetic products are lightly regulated by US federal regulators. Unlike drugs, which mus...
  • Regulatory NewsRegulatory News

    This Week in Medical Device Regulation (17-21 November 2014)

    Welcome to This Week in Medical Device Regulation, your weekly review of regulatory news and intelligence. Regulatory Focus FDA Decides to Delay UDI Labeling Rule for Some Orthopedic Implants ( Regulatory Focus ) Pacemakers Get Hacked On TV, But Could It Happen In Real Life? ( Regulatory Focus ) Legislators Call on FDA to Study use of Plastic Microbeads in Toothpastes ( Regulatory Focus ) New Electronic Formatting Requirements in Canada for Class III and IV MDL Appl...
  • Regulatory NewsRegulatory News

    This Week in Pharmaceutical Regulation (17-21 November 2014)

    Welcome to This Week in Pharmaceutical Regulation, your weekly review of regulatory news and intelligence. Regulatory Focus FDA Explains How its New Incentive Program for Rare Pediatric Disease Treatments Works ( Regulatory Focus ) Proposed Rule Calls for Clinical Trial Results to be Reported, Even When Product Isn't Approved ( Regulatory Focus ) How Should FDA Prioritize the Review of Important New Generic Drugs? Agency Wants to Know ( Regula...
  • Regulatory NewsRegulatory News

    This Week in Pharmaceutical Regulation (10-14 November 2014)

    Welcome to This Week in Pharmaceutical Regulation, your weekly review of regulatory news and intelligence. Regulatory Focus EMA's Top Drug Regulator, Guido Rasi, Forced to Step Down ( Regulatory Focus ) Bill to Speed up Approvals for Sunscreen Ingredients, Other Drugs Awaits Obama's Signature ( Regulatory Focus ) US Senate Unveils Major Changes to FDA Program in Hopes of Fighting Ebola ( Regulatory Focus ) FDA Says it Discov...
  • Regulatory NewsRegulatory News

    This Week in Medical Device Regulation (10-14 November 2014)

    • 16 November 2014
    Welcome to This Week in Medical Device Regulation, your weekly review of regulatory news and intelligence. Regulatory Focus FDA Authorizes Sixth Device to Help in Fight Against Ebola ( Regulatory Focus ) FDA Provides Some Clarity to Complex Regulatory Environment for Molecular Diagnostics ( Regulatory Focus ) Major Changes to Medical Device Registration Process in Japan ( Regulatory Focus ) US: Medical Devices FDA's Gutierrez clarifies LDT...
  • Regulatory NewsRegulatory News

    This Week in Medical Device Regulation (3-7 November 2014)

    Welcome to This Week in Medical Device Regulation, your weekly review of regulatory news and intelligence. Regulatory Focus: FDA Will Soon Need to Publish More Information About the Outside Standards it Uses ( Regulatory Focus ) FDA Looking for a Leader for its New Device Testing Division ( Regulatory Focus ) Is FDA Listening Enough to Patients? Agency Wants Feedback ( Regulatory Focus ) ANVISA Allowing Automatic Deadline Extensions for Medical Device Regist...
  • Regulatory NewsRegulatory News

    This Week in Pharmaceutical Regulation (3-7 November 2014)

    Welcome to This Week in Pharmaceutical Regulation, your weekly review of regulatory news and intelligence. Regulatory Focus: Is FDA Listening Enough to Patients? Agency Wants Feedback ( Regulatory Focus ) Report Finds FDA Slow to Approve CNS Drugs, But Getting Faster ( Regulatory Focus ) FDA's Regulation of Generic Manufacturers, Clinical Trials Comes Under Scrutiny ( Regulatory Focus ) In Unusual Letter, FDA Dismantles Company's Drug Superiority Claims ( Regulator...